DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+6.89%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$53.9B
AUM Growth
-$1.63B
(-2.9%)
Cap. Flow
-$3.64B
Cap. Flow
% of AUM
-6.75%
Top 10 Holdings %
Top 10 Hldgs %
26.17%
Holding
1,489
New
41
Increased
394
Reduced
550
Closed
60
Top Buys
| 1 |
CVS Health
CVS
|
$78.6M |
| 2 |
Sysco
SYY
|
$55.4M |
| 3 |
Progressive
PGR
|
$44.2M |
| 4 |
Exxon Mobil
XOM
|
$42.4M |
| 5 |
Mondelez International
MDLZ
|
$27.4M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$1.67B |
| 2 |
Broadcom
AVGO
|
$1.19B |
| 3 |
Amazon
AMZN
|
$116M |
| 4 |
Canadian Natural Resources
CNQ
|
$74.1M |
| 5 |
Gilead Sciences
GILD
|
$66M |
Sector Composition
| 1 | Technology | 27.08% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 10.83% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Acuity Brands
AYI
$10.4B
| $4.08M | 0.01% |
15,242
-571
| -4% | -$153K |
|
627
Bio-Rad Laboratories Class A
BIO
$8B
| $4.03M | 0.01% |
12,211
-3,376
| -22% | -$1.11M |
|
628
Seagate
STX
$40B
| $4.02M | 0.01% |
37,100
+1,912
| +5% | +$207K |
|
629
Credicorp
BAP
$20.7B
| $4M | 0.01% |
21,871
| – | – |
|
630
ZTO Express
ZTO
$14.7B
| $3.99M | 0.01% |
162,421
-571
| -0.4% | -$14K |
|
631
Northern Trust
NTRS
$24.3B
| $3.94M | 0.01% |
43,871
+158
| +0.4% | +$14.2K |
|
632
J.M. Smucker
SJM
$12B
| $3.92M | 0.01% |
32,604
+8,201
| +34% | +$986K |
|
633
Bunge Global
BG
$16.9B
| $3.91M | 0.01% |
40,687
-2,145
| -5% | -$206K |
|
634
KeyCorp
KEY
$20.8B
| $3.91M | 0.01% |
238,031
+1,645
| +0.7% | +$27K |
|
635
Darling Ingredients
DAR
$5.07B
| $3.9M | 0.01% |
103,814
+71,314
| +219% | +$2.68M |
|
636
Maximus
MMS
$4.97B
| $3.85M | 0.01% |
42,100
| – | – |
|
637
Sarepta Therapeutics
SRPT
$1.96B
| $3.83M | 0.01% |
30,945
| – | – |
|
638
Roivant Sciences
ROIV
$8.82B
| $3.83M | 0.01% |
350,000
| – | – |
|
639
Exact Sciences
EXAS
$10.2B
| $3.82M | 0.01% |
58,333
-1,558
| -3% | -$102K |
|
640
Ionis Pharmaceuticals
IONS
$9.76B
| $3.8M | 0.01% |
93,807
| – | – |
|
|
ITCI
641
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.8M | 0.01% |
51,997
-502
| -1% | -$36.7K |
|
642
Highwoods Properties
HIW
$3.44B
| $3.8M | 0.01% |
118,192
-3,320
| -3% | -$107K |
|
643
Burlington
BURL
$18.4B
| $3.76M | 0.01% |
14,292
-4,360
| -23% | -$1.15M |
|
644
Loews
L
$20B
| $3.74M | 0.01% |
47,513
-4,178
| -8% | -$329K |
|
|
XIFR
645
XPLR Infrastructure, LP
XIFR
$976M
| $3.73M | 0.01% |
127,971
+101,900
| +391% | +$2.97M |
|
646
Portland General Electric
POR
$4.69B
| $3.7M | 0.01% |
78,278
+59,423
| +315% | +$2.81M |
|
647
FirstEnergy
FE
$25.1B
| $3.68M | 0.01% |
84,565
-894
| -1% | -$38.9K |
|
648
Align Technology
ALGN
$10.1B
| $3.64M | 0.01% |
14,424
-832
| -5% | -$210K |
|
649
Brookfield Asset Management
BAM
$94B
| $3.61M | 0.01% |
79,236
-10,572
| -12% | -$481K |
|
650
Insmed
INSM
$30.7B
| $3.6M | 0.01% |
50,000
| – | – |
|